Ignite Creation Date:
2024-05-05 @ 5:24 PM
Last Modification Date:
2024-10-26 @ 9:31 AM
Study NCT ID:
NCT00443976
Status:
COMPLETED
Last Update Posted:
2023-08-04
First Post:
2007-03-05
Brief Title:
Aurora Kinase Inhibitor AT9283 in Treating Patients With Advanced or Metastatic Solid Tumors or Non-Hodgkins Lymphoma
Sponsor:
NCIC Clinical Trials Group
Organization:
Canadian Cancer Trials Group
Organization Data
Organization:
Canadian Cancer Trials Group
Class:
NETWORK
Study ID:
I181
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
NCIC Clinical Trials Group
Lead Sponsor Class:
NETWORK
Responsible Party:
None
Responsible Party Title:
None
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
None
Old Name:
None
Old Organization:
None
Collaborators
| Name | Class |
|---|---|
| Astex Pharmaceuticals Inc | INDUSTRY |